TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: mFARS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Oral Health Status Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge, Attitude, and Practice (KAP) Score Change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Completion of data collection measures
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: median change in modified Rankin scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mindfulness Training (MT)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Psychological Well-Being (PWB)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Walking speed deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of bacterial meningitis
Endpoint domain: Adverse events/effects
Primary endpoint: Perceived risk of harm
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived need for a referral
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: freedom from PTS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median total Villalta score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rVCSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to primary clinical outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PROMIS-PI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PROMIS-PF scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: SGA at birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Vasomotor symptoms (VMS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Menstrual symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Late preterm respiratory morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: self-efficacy to avoid fighting
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: non-partner aggression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: violence consequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline mixed-meal tolerance test C-peptide weighted mean AUC0-120 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: EBV reactivation
Endpoint domain: Adverse events/effects
Primary endpoint: Houpt ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of hospital bed days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Overall treatment episodes (inpatient + HT days)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Congestion management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Supervisory neglect incidents
Endpoint domain: Adverse events/effects
Primary endpoint: Fentanyl consumption during the first postoperative 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fentanyl consumption during the first postoperative 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score during coughing at 24 hours postoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in fear
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Good surgical outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRD1 increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inter‐eyelid MRD 1 difference improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CBT response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy of control over negative affect drinking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: control over alcohol consumption
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: decreased social drinking motives
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: 18-month changes in a global composite score capturing attention regulation, socioemotional, and self-knowledge capacities
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Frequency of weekly bowel movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: swallowing dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of dressings required
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rates of harmfulness
Endpoint domain: Adverse events/effects
Primary endpoint: Side effects related to the head or mind
Endpoint domain: Adverse events/effects
Primary endpoint: respiratory function parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: respiratory muscle strength parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: peak cough flows
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Academic self-concept
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: bladder cancer survival
Endpoint domain: Mortality/survival
Primary endpoint: Cardiometabolic indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Patient health rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medical recommendations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Irisin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy and safety of IVUS-guided vs angiography-guided DK crush stenting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post‐CCRT ADC50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interpretive bias to threat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety outcomes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Preventive visit attendance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Grade of RIWM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACP documentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of neoplasias identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of patients with a dominant neurological syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of myopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV1% increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Virus detection frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rates of PP‐CSF use
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rates of FN
Endpoint domain: Adverse events/effects
Primary endpoint: Time taken to achieve effective airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First-time insertion success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle activity of the gastrocnemius
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Portions of remnant epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: M-Carn levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: high-intensity exercise tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average level of challenging behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean PICS scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ibuprofen dosage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: FSMC score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Mean daily crying time
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: win ratio for primary outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Myocardial ischaemic burden (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Catheter plugging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood return
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD34/CD184 cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arterial stiffness measures (augmentation Index and pulse wave analysis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: LDL: HDL ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in urinary [tissue inhibitor of metalloproteinases‐2]*[insulin‐like growth factor‐binding protein 7]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in dyslipidemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Granulation tissue coverage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thickness of granulation tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of bleeding of wound
Endpoint domain: Adverse events/effects
Primary endpoint: improvement in joint pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in urinary frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cognitive and psychiatric difficulties
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Risk-taking behavior
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: gains in walking performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in executive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hazard of acute hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: incidence rate of acute hospitalizations
Endpoint domain: Mortality/survival
Primary endpoint: proportion of residents with LTC transition
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in prevalence of metabolic syndrome risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decrease in cardiovascular risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of lymphedema
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of oral anticoagulant counseling
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean score change on ADAS-cog-12 from baseline to month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Willingness to pay (WTP) change
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of caregivers willing to pay
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in depression from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with MIT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Executive Function (EF) performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Horizontal bone resorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: binocular DCNVA at 40 cm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: binocular photopic and mesopic DCNVAs at 33 cm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: photopic high-contrast and low-contrast CDVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in 48-h-cSBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in office-pulse-wave-velocity (PWV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in 48-h-central-pulse-pressure (cPP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite primary outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Syncope recurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3 or 4 surgical adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: minimal residual disease remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: future PSA tests
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Score on the 6-item Hamilton Depression Rating Scale (HDRS-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impressions-Severity of Illness scale (CGI-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in absolute left ventricular mass (LVM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: decreases in explicit attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cfPWV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: bfPWV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: postoperative consumption of tramadol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grade I‐II leucopoenia
Endpoint domain: Adverse events/effects
Primary endpoint: upper and lower gastrointestinal reactions
Endpoint domain: Adverse events/effects
Primary endpoint: time in sedentary bouts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vigorous-intensity physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moderate physical activity (MPA) bouts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in prescribed IFX
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in prescribed ETN
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time to drug switch
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: symbolic math performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini-Mental State Examination (MMSE) score ≤24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: semantic verbal fluency test scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time to first invasive procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Worsening of quality of life related to urinary and bowel symptoms
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of adverse events (urinary retention and dysuria)
Endpoint domain: Adverse events/effects
Primary endpoint: mental quality of life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mean DBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: decreased fast-twitch motor recruitment in the erector spinae muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: fatigue-resistance of the back muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Migraine reduction of more than 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of migraine attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of study procedures
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Waiting time for diagnosis of acute appendicitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic specificity of appendicitis diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain increase following loading conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RMSE (Root Mean Square Error)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GMFM-66 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PEDI scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: lower systolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: reduced salivary alpha-amylase concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved overall positive affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of participants with undetectable viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence rates to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of visits to the emergency department or admissions to hospital per patient
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: At least one grade 3 toxicity reported
Endpoint domain: Adverse events/effects
Primary endpoint: Functional assessment of cancer therapy trial outcome index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Motivation to start exercise
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean difference in postoperative VAS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Allogeneic blood transfusion requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Median time to admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Median time to operative treatment
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: xerostomia questionnaire summary score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: unstimulated whole saliva flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glasgow Coma Criterion (GCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Program fidelity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intervention participation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: 20TT performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GUA odorant detection thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GCS scores sensitivity and specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAMD-17 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean acquisition time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation dose (CTDIvol and ED)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total response rates to omalizumab at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Level 2 hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Level 1 hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Symptom improvement rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New-onset end-stage renal disease requiring chronic dialysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Post-operative pressure ulcer formation
Endpoint domain: Adverse events/effects
Primary endpoint: Intermittent pressure (IP) during deflation cycles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: executive function Z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CDR-global
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CDR-SOB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Median z scores for weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes